Predictors of colorectal cancer screening: A comparison of men and women

Canadian Journal of Gastroenterology

Volumn 19, Issue 6, 2005, Pages 343-349

  McGregor, S Elizabeth ^a   Bryant, Heather E ^a  

^a Alberta Cancer Board   (Canada)

Author keywords

Alberta; Cohort; Colorectal cancer; Health surveys; Mass screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANADA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; EMPLOYMENT; FAMILY HISTORY; FECES ANALYSIS; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MALE; MAMMOGRAPHY; OCCULT BLOOD TEST; PAPANICOLAOU TEST; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEX DIFFERENCE; SIGMOIDOSCOPY;

EID: 22444442619     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/359243     Document Type: Article

References (53)

1. National Cancer Institute of Canada. Canadian Cancer Statistics 2004. Toronto: National Cancer Institute of Canada, 2004.
2. Stephenson BM, Finan PJ, Gascoyne J, Garbett F, Murday VF, Bishop DT. Frequency of familial colorectal cancer. Br J Surg 1991;78:1162-6.
3. Bresalier RS, Kim YS. Malignant neoplasms of the large intestine. In: Feldman M, Scharschmidt BF, Sleisnger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. Philadelphia: WB Saunders Co, 1998:1906-42.
4. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
6. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial. Dis Colon Rectum 1994;37:115-9.
7. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
8. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
9. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
10. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998;317:559-65.
11. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
12. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
13. Glick SN, Ralls PW, Balfe DM, et al. Screening for colorectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215(Suppl):231-7.
14. Ontario Expert Panel. Colorectal Cancer Screening: Final Report of the Ontario Expert Panel. Toronto: Cancer Care Ontario, 1999.
15. US Preventive Services Task Force. Screening for colorectal cancer: Recommendation and rationale. Ann Intern Med 2002;137:129-31.
16. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001;165:206-8.
17. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol 2004;18:93-9.
18. Mills C, Stephens T, Wilkins K. Summary report of the workshop on data for monitoring tobacco use. Health Rep 1994;6:377-87.
19. Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ. Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 1988;128:740-8.
20. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
21. Statistics Canada. Canadian Community Health Survey (CCHS) Questionnaire for Cycle 1.1. September, 2000 - November, 2001. (Version current at May 17, 2005).
22. UCLA Center for Health Policy Research. 2001 California Health Interview Survey Adult Questionnaire (Respondents Age 18 and Older). (Version current at May 17, 2005).
23. Health Canada. Canadian Guidelines for Body Weight Classification in Adults. Ottawa: Health Canada, 2003.
24. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21:132-7.
25. Balluz L, Ahluwalia IB, Murphy W, Mokdad A, Giles W, Harris VB. Surveillance for certain health behaviors among selected local areas - United States, Behavioral Risk Factor Surveillance System, 2002. MMWR Surveill Summ 2004;53:1-100.
26. Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol 2004;99:1141-4.
27. Center for Disease Control. National Colorectal Cancer Awareness Month - March 2001. MMWR 2001;50:161.
28. Bell RA, Shelton BJ, Paskett ED. Colorectal cancer screening in North Carolina: Associations with diabetes mellitus and demographic and health characteristics. Prev Med 2001;32:163-7.
29. Vernon SW. Participation in colorectal cancer screening: A review. J Natl Cancer Inst 1997;89:1406-22.
30. Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L. Colorectal cancer screening participation: Comparisons with mammography and prostate-specific antigen screening. Am J Public Health 2001;91:1264-72.
31. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100:2093-103.
32. Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health 2004;20:118-24.
33. Seeff LC, Shapiro JA, Nadel MR. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract 2002;51:761-6.
34. Adams EK, Thorpe KE, Becker ER, Joski PJ, Flome J. Colorectal cancer screening, 1997-1999: Role of income, insurance and policy. Prev Med 2004;38:551-7.
35. Singh SM, Paszat LF, Li C, He H, Vinden C, Rabeneck L. Association of socioeconomic status and receipt of colorectal cancer investigations: A population-based retrospective cohort study. CMAJ 2004;171:461-5.
36. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
37. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med 2004;19:332-8.
38. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082-91.
39. Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract 2000;13:1-10.
40. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med 2002;23:28-35.
41. McCaul KD, Tulloch HE. Cancer screening decisions. J Natl Cancer Inst Monogr 1999;52-8.
42. Slevin TJ, Donnelly N, Clarkson JP, English DR, Ward JE. Prostate cancer testing: Behaviour, motivation and attitudes among Western Australian men. Med J Aust 1999;171:185-8.
43. Cowen ME, Kattan MW, Miles BJ. A national survey of attitudes regarding participation in prostate carcinoma testing. Cancer 1996;78:1952-7.
44. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal. cancer screening. J Fam Pract 1997;45:211-8.
45. Solomon MJ, McLeod RS. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination. CMAJ 1994;150:1961-70.
46. McLeod RS; Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer: A systematic review of the evidence. Can J Gastroenterol 2001;15:647-60.
47. Levin B, Hawley ST. Average-risk screening: Is public policy compatible with individual needs? Surg Oncol Clin N Am 2000;9:665-77.
48. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997;157:408-16.
49. Center for Disease Control. Trends in Screening for Colorectal Cancer - United States, 1997 and 1999. MMWR 2001;50:162-6.
50. Nelson DE, Bland S, Powell-Griner E, et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA 2002;287:2659-67.
51. Feightner JW. Screening for prostate cancer. In: Canadian Task Force on Periodic Health Examination. Ottawa: Health Canada, 1994:812-23.
52. Screening Working Group of the Canadian Strategy for Cancer Control. Population Cancer Screening in Canada: Strategic Priorities. Toronto: Canadian Strategy for Cancer Control, 2001.
53. Coombs A, Jones-McLean E, Le-Petit C, et al. Technical Report for the National Committee on Colorectal Cancer Screening. 2002. (Version current at May 17, 2005).